Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its structure supports peptide mimicry, making it valuable in medicinal chemistry for designing drugs with improved metabolic stability and target selectivity. Commonly employed in asymmetric synthesis due to the presence of a stereogenic center, enabling the production of enantiomerically pure therapeutics. Also utilized in the preparation of enzyme inhibitors where the methoxyphenyl and Boc-protected amino group facilitate specific binding interactions.